| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Creager Stephen E |
VP and General Counsel |
• – – |
2008-03-31 |
4 |
D |
$3.78 |
$5,254 |
D/D |
(1,390) |
17,217 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2008-03-31 |
4 |
D |
$3.78 |
$3,587 |
D/D |
(949) |
467,553 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2008-03-31 |
4 |
D |
$3.78 |
$1,796 |
D/D |
(475) |
30,343 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2008-03-31 |
4 |
D |
$3.78 |
$4,665 |
D/D |
(1,234) |
60,465 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2008-03-31 |
4 |
D |
$3.78 |
$3,901 |
D/D |
(1,032) |
35,653 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2008-03-29 |
4 |
OE |
$3.78 |
$34,020 |
D/D |
9,000 |
225,453 |
|
- |
|
| Delli- Santi John S |
EVP and CCO |
• – – |
2008-03-19 |
4 |
D |
$3.99 |
$9,384 |
D/D |
(2,352) |
3,148 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2008-03-14 |
4 |
S |
$4.00 |
$19,151 |
D/D |
(4,700) |
466,002 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2008-02-27 |
4 |
D |
$4.32 |
$6,929 |
D/D |
(1,604) |
15,357 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2008-02-27 |
4 |
D |
$4.32 |
$6,152 |
D/D |
(1,424) |
58,449 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2008-02-27 |
4 |
D |
$4.32 |
$6,152 |
D/D |
(1,424) |
33,435 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2008-02-27 |
4 |
D |
$4.32 |
$3,279 |
D/D |
(759) |
29,568 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2008-02-27 |
4 |
D |
$4.32 |
$4,920 |
D/D |
(1,139) |
470,702 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2008-01-10 |
4 |
D |
$5.58 |
$6,618 |
D/D |
(1,186) |
31,109 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-20 |
4 |
S |
$5.50 |
$9,460 |
D/D |
(1,720) |
467,121 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-19 |
4 |
S |
$5.50 |
$4,315 |
D/D |
(780) |
468,841 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-19 |
4/A |
S |
$5.53 |
$3,875 |
D/D |
(700) |
468,841 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-17 |
4 |
S |
$5.50 |
$36,276 |
D/D |
(6,500) |
469,621 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-10 |
4 |
S |
$5.72 |
$52,242 |
D/D |
(9,000) |
476,121 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-12-03 |
4 |
S |
$5.50 |
$98,761 |
D/D |
(17,849) |
485,121 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-11-30 |
4 |
S |
$5.50 |
$100,449 |
D/D |
(18,151) |
502,970 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-11-16 |
4 |
D |
$5.24 |
$8,321 |
D/D |
(1,588) |
521,121 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-11-05 |
4 |
S |
$5.65 |
$51,351 |
D/D |
(9,000) |
517,709 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-10-29 |
4 |
S |
$5.81 |
$52,805 |
D/D |
(9,000) |
526,709 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2007-10-22 |
4 |
S |
$5.73 |
$51,990 |
D/D |
(9,000) |
535,709 |
|
- |
|
291 Records found
|
|
Page 9 of 12 |
|
|
